Related Experiment Video
Updated: Nov 2, 2025

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
Published on: February 28, 2015
Selection of a Structure-Switching Aptamer for the Specific Methotrexate Detection
Junqing He1, Junyan Wang2, Min Zhang1
1School of Chemistry and Molecular Engineering, Shanghai Key Laboratory for Urban Ecological Processes and Eco-Restoration, East China Normal University, Dongchuan Road 500, Shanghai 200241, China.
A new DNA aptamer sensor accurately detects methotrexate (MTX) levels in blood. This rapid, selective method offers a simpler alternative for monitoring MTX drug concentrations, improving patient safety.
Area of Science:
- Biotechnology
- Analytical Chemistry
- Molecular Diagnostics
Background:
- Methotrexate (MTX) is a vital anti-cancer drug, but high doses necessitate careful blood concentration monitoring due to potential severe side effects.
- Current methods for MTX quantification are often complex, time-consuming, and costly, limiting routine clinical application.
- Developing a rapid, selective, and cost-effective assay for MTX monitoring is crucial for optimizing patient treatment and safety.
Purpose of the Study:
- To develop a novel, highly selective DNA aptamer for recognizing Methotrexate (MTX).
- To create a structure-switching fluorescent sensor for rapid and specific MTX detection.
- To evaluate the analytical performance of the developed sensor for MTX monitoring in biological samples.
Main Methods:
- Selection of a specific DNA aptamer for MTX using the capture-systematic evolution of ligands by exponential enrichment (C-SELEX) technique.
- Design and implementation of a structure-switching fluorescent sensor utilizing the selected MTX aptamer.
- Validation of the sensor's performance, including linear detection range and limit of detection (LOD), in buffer and serum samples.
Main Results:
- A highly selective DNA aptamer capable of recognizing MTX was successfully developed.
- The structure-switching fluorescent sensor demonstrated specific and rapid MTX detection.
- The sensor exhibited excellent analytical performance with a low LOD of 0.03 μM in buffer and 0.18 μM in 50% serum, with linear ranges of 0.1-2 μM and 0.5-10 μM, respectively.
Conclusions:
- The developed DNA aptamer-based fluorescent sensor provides a sensitive, selective, and rapid method for MTX detection.
- This novel assay presents a promising alternative to conventional methods for clinical monitoring of MTX blood concentrations.
- The aptamer and sensor design hold potential for inspiring future developments in therapeutic drug monitoring sensors.
More Related Videos
03:38Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
Published on: October 6, 2022
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022